Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel neuraminidase inhibitors described by U. of Florida

March 11, 1999

Ziracin: lead compound from a new class of antibiotics in late-stage trials at Schering-Plough

March 10, 1999

Avanir submits additional efficacy data for docosanol cream to FDA

March 9, 1999

FDA advisory committee declines to recommend approval of Locilex

March 5, 1999

Taisho scientists isolate and and characterize new antifungal agent

March 5, 1999

Wyeth-Ayerst to market Abelcet in the U.K.

March 5, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

New lantibiotic isolated and characterized by U. of Maryland group

March 4, 1999

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

March 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...